Sign in
4

Changes in Ownership

Evommune, Inc. Filed Acc 0002092017-25-000007

Chief Scientific Officer acquired 3,175 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Patel Jeegar Pravinkumar Chief Scientific Officer 2025-11-07 Conversion +3,175 57,091 D
Derivatives
Patel Jeegar Pravinkumar Chief Scientific Officer 2025-11-07 Conversion · Series B Preferred Stock −25,000 0 D
Loading xslF345X05/form4-11122025_091148.xml…